Slate Medicines, Inc.
Pharmaceuticals · BOSTON, MA
PharmaceuticalsSEC Form D
Slate Medicines, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 11, 2026, reporting $9,999,992 raised toward a $130,000,000 offering.
Incorporated in Delaware and based in BOSTON, MA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Slate Medicines, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Andrew LevinDirector
- Cindy XiongDirector
- Tim LohoffDirector
- Neil BuckleyExecutive Officer · Director
- Sara PachecoExecutive Officer
- Gregory Frank OakesExecutive Officer
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised